SCHEMBL28528161

SCHEMBL28528161

O=[N+]([O-])/C=C\c1ccc(Cl)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FBP1 P09467 13/20 1.00
EGFR P00533 2/20 0.64
ALDH1A1 P00352 3/20 0.58
LMNA P02545 3/20 0.58
MAPT P10636 2/20 0.58
SMN1; SMN2 Q16637 2/20 0.58
TLR4 O00206 1/20 0.55
TLR2 O60603 1/20 0.55
ABL1 P00519 1/20 0.53
ABL2 P42684 1/20 0.53
MEN1 O00255 2/20 0.53
KMT2A Q03164 2/20 0.53
VCP P55072 1/20 0.53
HSP90AA1 P07900 2/20 0.52
S1PR4 O95977 1/20 0.51
HPGD P15428 1/20 0.51
S1PR1 P21453 1/20 0.51
MAPK1 P28482 1/20 0.51
CCR6 P51684 1/20 0.51
NPSR1 Q6W5P4 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL219463 1.00 FBP1 (1.00) FBP1EGFRALDH1A1LMNAMAPT
SCHEMBL219464 1.00 FBP1 (1.00) FBP1EGFRALDH1A1LMNAMAPT
SCHEMBL6910815 0.89 FBP1 (0.78) FBP1EGFRALDH1A1LMNAMAPT
SCHEMBL6910818 0.89 FBP1 (0.78) FBP1EGFRALDH1A1LMNAMAPT
SCHEMBL5924031 0.78 FBP1 (0.67) FBP1EGFRTLR4TLR2ABL1
SCHEMBL2077031 0.78 FBP1 (1.00) FBP1EGFRALDH1A1LMNAMAPT
SCHEMBL421633 0.78 FBP1 (0.64) FBP1EGFRALDH1A1LMNAMAPT
SCHEMBL102630 0.78 FBP1 (1.00) FBP1EGFRALDH1A1LMNAMAPT
SCHEMBL366121 0.78 FBP1 (1.00) FBP1EGFRALDH1A1LMNAMAPT
SCHEMBL1681205 0.78 FBP1 (1.00) FBP1EGFRALDH1A1LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025045746-A1 PYRAZOLE DERIVATIVES AS SARM1 INHIBITORS USEFUL FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS F. HOFFMANN-LA ROCHE AG (CH) 2025-03-06 WO disclosed
CN-112250581-B Preparation method of trans-4-chloro-beta-nitrostyrene 湖南海利常德农药化工有限公司 2023-03-17 CN disclosed
CN-112250581-A Preparation method of trans-4-chloro-beta-nitrostyrene 湖南海利常德农药化工有限公司 2021-01-22 CN disclosed